Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal
Nature.com - 05 Mar 2024Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study | Blood Cancer Journal ...